Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology--a rebuttal.
Vasvari
G
G
Dyckhoff
G
G
Herold-Mende
C
C
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D017209:Apoptosis; D002266:Carboxymethylcellulose Sodium / Q000737:chemistry; D045744:Cell Line, Tumor; D048429:Cell Size / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology*; D042783:Endothelial Cells / Q000187:drug effects* / Q000473:pathology*; D004730:Endothelium, Vascular / Q000166:cytology*; D006801:Humans; D012997:Solvents; D013792:Thalidomide / Q000494:pharmacology*
D020533:Angiogenesis Inhibitors; D012997:Solvents; D013792:Thalidomide; D004317:Doxorubicin; D002266:Carboxymethylcellulose Sodium; D004121:Dimethyl Sulfoxide